Kura Oncology, Inc.
KURA- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001422143
In the last 90 days, Kura Oncology, Inc. insiders filed 2 open-market purchases and 8 sales; 221 institutions reported holding it in 13F filings for Q2 2026, worth $953.1M in total; no superinvestor holds it.
Q2 2022 vs. Q1 2022
How the institutions holding Kura Oncology, Inc. changed between Q1 2022 and Q2 2022.
All holders in Q2 2022All holders in Q1 2022
| Measure | Q1 2022 | Of which not filed for Q2 2022 | Q2 2022 | Change |
|---|---|---|---|---|
| Holders | 152 | 2 | 148 | −2 |
| Shares | 66.7M | 47.6K | 68.7M | +2.02M (+3.0%) |
| Value | $1.06B | $765.0K | $1.26B | +$201.6M (+19.1%) |
2 institutions that held it in Q1 2022 haven't filed for Q2 2022 yet. Not filing isn't selling, so the changes leave them out.
New holders (19)
Institutions that held Kura Oncology, Inc. at the end of Q2 2022 but not at the end of Q1 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Balyasny Asset Management LLC | 1,434,014 | $26.3M | 0.11% |
| Victory Capital Management Inc | 766,318 | $14.0M | 0.02% |
| Thunderbird Partners LLP | 512,727 | $9.40M | 2.23% |
| Altium Capital Management LP | 147,000 | $2.69M | 1.14% |
| Thrivent Financial for Lutherans | 89,487 | $1.64M | 0.00% |
| 1492 Capital Management LLC | 40,173 | $736.0K | 0.49% |
| Alps Advisors Inc | 39,525 | $724.0K | 0.01% |
| Hennion & Walsh Asset Management, Inc. | 33,908 | $622.0K | 0.04% |
| Squarepoint Ops LLC | 33,817 | $620.0K | 0.01% |
| Trexquant Investment LP | 19,775 | $362.0K | 0.02% |
| Mirae Asset Global Investments Co., Ltd. | 19,604 | $359.0K | 0.00% |
| Fred Alger Management, LLC | 19,054 | $349.0K | 0.00% |
| Panagora Asset Management Inc | 11,590 | $212.0K | 0.00% |
| Delphia (USA) Inc. | 11,430 | $210.0K | 0.14% |
| Principal Financial Group Inc | 10,788 | $198.0K | 0.00% |
| E Fund Management Co., Ltd. | 10,573 | $194.0K | 0.02% |
| Allworth Financial LP | 8 | $0 | 0.00% |
| Parallel Advisors, LLC | 11 | $0 | 0.00% |
| Dark Forest Capital Management LP | 7 | $0 | 0.00% |
Sold out (21)
Institutions that held Kura Oncology, Inc. at the end of Q1 2022 and filed for Q2 2022 without it.
| Institution | Shares, Q1 2022 | Value, Q1 2022 |
|---|---|---|
| Baker Bros. Advisors LP | 274,458 | $4.41M |
| Ci Investments Inc. | 84,902 | $1.36M |
| Susquehanna International Group, LLP | 61,529 | $989.0K |
| Ergoteles LLC | 32,159 | $517.0K |
| HRT Financial LP | 32,072 | $515.0K |
| Winton Group Ltd | 20,196 | $325.0K |
| Caxton Associates LP | 15,194 | $244.0K |
| Handelsbanken Fonder AB | 14,800 | $238.0K |
| Graham Capital Management, L.P. | 14,376 | $231.0K |
| Campbell & CO Investment Adviser LLC | 13,848 | $223.0K |
| Teacher Retirement System of Texas | 11,459 | $184.0K |
| Bridgefront Capital, LLC | 11,206 | $180.0K |
| Group One Trading, L.P. | 6,296 | $101.0K |
| Point72 Hong Kong Ltd | 2,927 | $47.0K |
| Aquatic Capital Management LLC | 200 | $3.00K |
| Ellevest, Inc. | 123 | $2.00K |
| EverSource Wealth Advisors, LLC | 135 | $2.00K |
| Central Trust Co | 16 | $0 |
| The PNC Financial Services Group, Inc. | 27 | $0 |
| Northwestern Mutual Wealth Management Co | 10 | $0 |
| CWM, LLC | 10 | $0 |
Not filed for Q2 2022 yet (2)
Institutions that held Kura Oncology, Inc. at the end of Q1 2022 and haven't filed a 13F for Q2 2022. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q1 2022 | Value, Q1 2022 |
|---|---|---|
| Parametric Portfolio Associates LLC | 39,942 | $642.0K |
| Amalgamated Financial Corp. | 7,650 | $123.0K |